Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer
Stopped Committee could not find that the regulatory approval are met to re-approve this study.
Conditions
- Prostate Adenocarcinoma
- PSA Level Greater Than Ten
- Stage IIB Prostate Cancer AJCC v8
- Stage III Prostate Cancer AJCC v8
- Stage IIIA Prostate Cancer AJCC v8
- Stage IIIB Prostate Cancer AJCC v8
- Stage IIIC Prostate Cancer AJCC v8
- Stage IV Prostate Cancer AJCC v8
- Stage IVA Prostate Cancer AJCC v8
- Stage IVB Prostate Cancer AJCC v8
Interventions
- DRUG: Hyperpolarized Carbon C 13 Pyruvate
- PROCEDURE: Magnetic Resonance Spectroscopic Imaging
Sponsor
M.D. Anderson Cancer Center
Collaborators